SMPD1 (Sphingomyelin phosphodiesterase) variants and mutations
SMPD1 (also known as Sphingomyelin phosphodiesterase) is a human protein-coding gene encoding a sphingomyelin phosphodiesterase protein. It hydrolyzes sphingomyelin to ceramide in lysosomes and participates in membrane-lipid turnover and stress signaling. Biallelic loss-of-function variants cause acid sphingomyelinase deficiency, including Niemann-Pick disease types A and B. This analysis covers 1,242 SMPD1 variants and mutations. Of these, 77% have computational variant effect predictions. Disease context includes Niemann-Pick disease type A, Niemann-Pick disease type B, and Niemann-Pick disease. Example SMPD1 variants include P2L, P2R, and P2S.
Variant analysis overview
- Gene: SMPD1
- Protein: Sphingomyelin phosphodiesterase
- UniProt accession: P17405
- Organism: Homo sapiens
- Variants analyzed: 1242
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 978 unspecified-consequence records; 96 missense variants; 91 synonymous variants; 47 frameshift variants; 3 stop-gained variants; 10 in-frame deletions; 9 in-frame insertions; 2 splice-region variants; 5 substitution
- Prediction scores: 951 variants have prediction scores (77% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Niemann-Pick disease type A, Niemann-Pick disease type B, Niemann-Pick disease, acid sphingomyelinase deficiency, lysosomal storage disease, Parkinson disease, Alzheimer disease, neurodegenerative disease, multiple sclerosis, hereditary disease, Niemann-Pick disease, type C1, Intellectual disability.
Protein structure and variant hotspots
- Protein features: 1 domains; 8 binding sites; 7 post-translational modification sites.
- Structural context: 210 variants have structural context.
- PTM context: 12 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SMPD1 variants
Examples include P2L, P2R, P2S, P2T, P2P, R3C, R3H, R3L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- P2L (p.Pro2Leu), ExAC rs769252257, TOPMed rs769252257, gnomAD rs769252257, REVEL 0.10, CADD 14.80
- P2R (p.Pro2Arg), ExAC rs769252257, TOPMed rs769252257, gnomAD rs769252257, REVEL 0.12, CADD 21.90
- P2S (p.Pro2Ser), NCI-TCGA Cosmic COSV5497, cosmic curated COSV54970, REVEL 0.11, CADD 16.90, Variant assessed as somatic; moderate impact.
- P2T (p.Pro2Thr), gnomAD 11-6390602-C-A, REVEL 0.12, CADD 12.90
- P2P (p.Pro2Pro), gnomAD 11-6390604-C-T, CADD 9.54
- R3C (p.Arg3Cys), ExAC rs772745537, gnomAD rs772745537, REVEL 0.03, CADD 15.40
- R3H (p.Arg3His), rs199836262, ClinGen CA5852452, cosmic curated COSV54968, ClinVar RCV000397745, REVEL 0.02, CADD 9.65, Conflicting interpretations, SMPD1-related disorder; Niemann-Pick disease, type A; Niemann-Pick disease, type
- R3L (p.Arg3Leu), 1000Genomes rs199836262, ESP rs199836262, ExAC rs199836262, TOPMed rs199836262, REVEL 0.04, CADD 10.20, Likely benign
- Y4H (p.Tyr4His), rs1400503556, ClinGen CA379366399, ClinVar RCV001279277, TOPMed rs1400503556, Uncertain significance, Sphingomyelin/cholesterol lipidosis
- Y4N (p.Tyr4Asn), TOPMed rs1400503556, Uncertain significance
- Y4F (p.Tyr4Phe), gnomAD 11-6390605-C-CGCT, CADD 19.80
- Y4* (p.Tyr4Ter), gnomAD 11-6390610-C-G, CADD 32.00
- G5R (p.Gly5Arg), gnomAD rs1283979194, REVEL 0.02, CADD 18.20
- G5V (p.Gly5Val), gnomAD 11-6390612-G-T, REVEL 0.06, CADD 21.60
- A6E (p.Ala6Glu), TOPMed rs1230304707, gnomAD rs1230304707, REVEL 0.05, CADD 8.19
- A6G (p.Ala6Gly), TOPMed rs1230304707, gnomAD rs1230304707, REVEL 0.08, CADD 1.74
- A6T (p.Ala6Thr), gnomAD rs1357318633, REVEL 0.02, CADD 12.50
- A6V (p.Ala6Val), TOPMed rs1230304707, gnomAD rs1230304707
- S7S (p.Ser7Ser), rs774163288, gnomAD 11-6390619-A-G, CADD 7.71
- L8F (p.Leu8Phe), TOPMed rs1847854475, gnomAD rs1847854475, REVEL 0.01, CADD 13.10
- L8P (p.Leu8Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L8V (p.Leu8Val), gnomAD 11-6390620-C-G, REVEL 0.01, CADD 4.62
- L8L (p.Leu8Leu), gnomAD 11-6390622-C-T, CADD 2.73
- R9C (p.Arg9Cys), TOPMed rs1440943859, gnomAD rs1440943859, REVEL 0.02, CADD 14.00
- R9H (p.Arg9His), ESP rs373013062, ExAC rs373013062, TOPMed rs373013062, gnomAD rs373013062, REVEL 0.01, CADD 22.40, Uncertain significance
- R9L (p.Arg9Leu), rs373013062, ClinGen CA5852455, ClinVar RCV001279278, ClinVar RCV006372416, REVEL 0.01, CADD 14.80, Uncertain significance, Inborn genetic diseases
- R9R (p.Arg9Arg), gnomAD 11-6390625-C-A, CADD 9.32
- Q10* (p.Gln10Ter), rs1205990349, ClinGen CA379366496, ClinVar RCV000664760, ClinVar RCV001386465, Pathogenic
- Q10E (p.Gln10Glu), gnomAD 11-6390626-C-G, REVEL 0.04, CADD 10.60
- Q10R (p.Gln10Arg), gnomAD 11-6390627-A-G, REVEL 0.02, CADD 11.80
- Q10H (p.Gln10His), gnomAD 11-6390628-G-C, REVEL 0.01, CADD 2.66
- S11C (p.Ser11Cys), Ensembl rs1847855159
- S11S (p.Ser11Ser), gnomAD 11-6390631-C-T, CADD 8.86
- C12* (p.Cys12Ter), cosmic curated COSV10513, ExAC rs767287886, gnomAD rs767287886, CADD 29.60, Likely benign
- C12F (p.Cys12Phe), gnomAD 11-6390633-G-T, REVEL 0.01, CADD 6.26
- C12Y (p.Cys12Tyr), gnomAD 11-6390633-G-A, REVEL 0.00, CADD 4.30
- R14G (p.Arg14Gly), Ensembl rs11544727
- R14S (p.Arg14Ser), gnomAD rs1185446981
- R14M (p.Arg14Met), gnomAD 11-6390639-G-T, REVEL 0.13, CADD 23.00
- R14K (p.Arg14Lys), gnomAD 11-6390639-G-A, REVEL 0.02, CADD 18.30
- R14T (p.Arg14Thr), gnomAD 11-6390639-G-C, REVEL 0.04, CADD 20.60
- S15Y (p.Ser15Tyr), gnomAD rs1367744440, REVEL 0.07, CADD 22.40
- S15S (p.Ser15Ser), rs1472913994, gnomAD 11-6390643-C-T, CADD 7.84
- G16C (p.Gly16Cys), ExAC rs760627709, gnomAD rs760627709, REVEL 0.04, CADD 14.90
- G16S (p.Gly16Ser), cosmic curated COSV10459, ExAC rs760627709, gnomAD rs760627709, REVEL 0.02, CADD 13.20
- G16V (p.Gly16Val), NCI-TCGA Cosmic COSV1001, cosmic curated COSV10019, Variant assessed as somatic; moderate impact.
- R17P (p.Arg17Pro), ExAC rs764126465, TOPMed rs764126465, gnomAD rs764126465, REVEL 0.06, CADD 15.00, Uncertain significance
- R17Q (p.Arg17Gln), rs764126465, ClinGen CA5852459, ClinVar RCV003071969, ExAC rs764126465, REVEL 0.05, CADD 15.30, Uncertain significance, Niemann-Pick disease, type B; Niemann-Pick disease, type A
- R17W (p.Arg17Trp), TOPMed rs1238859121, gnomAD rs1238859121, REVEL 0.02, CADD 10.90
- E18* (p.Glu18Ter), rs1428487333, ClinGen CA379366668, ClinVar RCV000667531, ClinVar RCV002530714, CADD 36.00, Pathogenic
- E18K (p.Glu18Lys), gnomAD rs1428487333, REVEL 0.01, CADD 21.30, Pathogenic
- Q19R (p.Gln19Arg), rs144465428, ClinGen CA5852460, ClinVar RCV000730126, ClinVar RCV002485872, REVEL 0.02, CADD 9.31, Conflicting interpretations, Inborn genetic diseases; Niemann-Pick disease, type B; Niemann-Pick disease, typ
- G20R (p.Gly20Arg), rs538153468, ClinGen CA5852461, ClinVar RCV000729102, ClinVar RCV002535106, REVEL 0.04, CADD 10.30, Uncertain significance, Niemann-Pick disease, type B; Niemann-Pick disease, type A; not provided
- Q21* (p.Gln21Ter), rs1554933751, ClinGen CA379366761, ClinVar RCV000670505, ClinVar RCV001868244, CADD 33.00, Pathogenic
- Q21K (p.Gln21Lys), rs1413550764, gnomAD 11-6390657-GA-G, CADD 19.40
- D22G (p.Asp22Gly), ExAC rs765485028, TOPMed rs765485028, gnomAD rs765485028, REVEL 0.01, CADD 15.70
- D22D (p.Asp22Asp), rs886048444, gnomAD 11-6390664-C-T, CADD 8.42
- G23E (p.Gly23Glu), Ensembl rs868461041
- G23R (p.Gly23Arg), ExAC rs750834930, gnomAD rs750834930, REVEL 0.04, CADD 8.46
- G23W (p.Gly23Trp), ExAC rs750834930, gnomAD rs750834930
- T24I (p.Thr24Ile), gnomAD 11-6390669-C-T, REVEL 0.14, CADD 15.40
- T24T (p.Thr24Thr), rs886043870, gnomAD 11-6390670-C-T, CADD 9.16
- A25T (p.Ala25Thr), ExAC rs758894722, REVEL 0.02, CADD 6.47
- A25del (p.Ala25del), rs1354375594, gnomAD 11-6390668-ACCG-A, CADD 12.30
- A25A (p.Ala25Ala), gnomAD 11-6390673-C-G, CADD 1.29
- G26R (p.Gly26Arg), rs766822201, ClinGen CA5852465, ClinVar RCV002400587, ClinVar RCV003481292, REVEL 0.01, CADD 10.50, Uncertain significance, not provided; Inborn genetic diseases
- G26A (p.Gly26Ala), gnomAD 11-6390675-G-C, REVEL 0.04, CADD 10.50
- G26G (p.Gly26Gly), rs747512813, gnomAD 11-6390676-A-T, CADD 7.28
- A27D (p.Ala27Asp), ExAC rs755490852, TOPMed rs755490852, gnomAD rs755490852, REVEL 0.04, CADD 9.56
- A27G (p.Ala27Gly), ExAC rs755490852, TOPMed rs755490852, gnomAD rs755490852, REVEL 0.02, CADD 8.95
- A27V (p.Ala27Val), ExAC rs755490852, TOPMed rs755490852, gnomAD rs755490852, REVEL 0.01, CADD 14.80
- A27T (p.Ala27Thr), gnomAD 11-6390677-G-A, REVEL 0.01, CADD 9.69
- A27S (p.Ala27Ser), gnomAD 11-6390677-G-T, REVEL 0.01, CADD 7.61
- A27P (p.Ala27Pro), gnomAD 11-6390677-G-C, REVEL 0.11, CADD 15.50
- A27A (p.Ala27Ala), rs902105449, gnomAD 11-6390679-C-T, CADD 9.43
- P28L (p.Pro28Leu), rs556155962, ClinGen CA5852469, ClinVar RCV000728133, ClinVar RCV000915596, REVEL 0.02, CADD 12.20, Conflicting interpretations, Inborn genetic diseases; not provided; Niemann-Pick disease, type B
- P28R (p.Pro28Arg), 1000Genomes rs556155962, ExAC rs556155962, TOPMed rs556155962, gnomAD rs556155962, Benign
- P28S (p.Pro28Ser), gnomAD rs1344220492
- P28H (p.Pro28His), gnomAD 11-6390681-C-A, REVEL 0.04, CADD 20.80
- P28P (p.Pro28Pro), rs577769499, gnomAD 11-6390682-C-T, CADD 9.17
- G29R (p.Gly29Arg), Ensembl rs1564921493, REVEL 0.02, CADD 0.01
- G29D (p.Gly29Asp), rs750157176, gnomAD 11-6390677-GC-G, CADD 18.00
- G29G (p.Gly29Gly), rs1193641309, gnomAD 11-6390685-A-G, CADD 9.29
- L30F (p.Leu30Phe), ESP rs376159116, TOPMed rs376159116, gnomAD rs376159116, REVEL 0.05, CADD 15.20
- L30R (p.Leu30Arg), Ensembl rs1590735050, REVEL 0.03, CADD 10.70
- L30V (p.Leu30Val), gnomAD 11-6390686-C-G, REVEL 0.02, CADD 13.80
- L30L (p.Leu30Leu), rs748793138, gnomAD 11-6390688-C-A, CADD 6.12
- p.Leu31 Trp32insSerGlyLeuLeu, gnomAD 11-6390680-C-CCCG, CADD 9.85
- L31L (p.Leu31Leu), rs2134005000, gnomAD 11-6390691-T-C, CADD 9.69
- W32* (p.Trp32Ter), rs786204506, ClinGen CA274022, ClinVar RCV000169189, ClinVar RCV001199862, CADD 38.00, Pathogenic
- W32G (p.Trp32Gly), gnomAD rs1239946469, REVEL 0.07, CADD 19.70
- W32C (p.Trp32Cys), gnomAD 11-6390694-G-C, REVEL 0.14, CADD 23.90
- M33I (p.Met33Ile), rs142178073, ClinGen CA5852471, ClinVar RCV000280282, ClinVar RCV000972278, REVEL 0.05, CADD 12.20, Benign/Likely benign, not specified; Niemann-Pick disease, type A; Niemann-Pick disease, type B
- M33L (p.Met33Leu), gnomAD 11-6390695-A-T, REVEL 0.03, CADD 4.18
- G34D (p.Gly34Asp), rs1554933790, ClinGen CA379367082, ClinVar RCV003138544, ClinVar RCV006460531, REVEL 0.07, CADD 17.30, Uncertain significance, not specified; not provided
- G34S (p.Gly34Ser), cosmic curated COSV54966, ExAC rs774047252, gnomAD rs774047252, REVEL 0.02, CADD 15.50, Uncertain significance, Niemann-Pick disease, type B; Niemann-Pick disease, type A
- G34V (p.Gly34Val), rs1554933790, TOPMed rs1554933790, REVEL 0.04, CADD 13.50, Uncertain significance
- G34A (p.Gly34Ala), gnomAD 11-6390696-TG-T, CADD 22.30
- G34G (p.Gly34Gly), rs889113421, gnomAD 11-6390700-C-G, CADD 10.40
- L35M (p.Leu35Met), 1000Genomes rs201367689, ESP rs201367689, TOPMed rs201367689, gnomAD rs201367689, Likely benign
- L35V (p.Leu35Val), rs201367689, ClinGen CA238623, ClinVar RCV000173158, ClinVar RCV001242007, REVEL 0.03, CADD 12.70, Conflicting interpretations, Inborn genetic diseases; not provided; Niemann-Pick disease, type B
- L35G (p.Leu35Gly), rs755988781, gnomAD 11-6390699-GCC-G, CADD 22.60
- L35A (p.Leu35Ala), gnomAD 11-6390700-CCTGGT, CADD 23.80
- L35L (p.Leu35Leu), rs201367689, gnomAD 11-6390701-C-T, CADD 9.01
- L35P (p.Leu35Pro), gnomAD 11-6390702-T-C, REVEL 0.06, CADD 14.70
- V36A (p.Val36Ala), rs1050228, ClinGen CA146857, cosmic curated COSV54967, ClinVar RCV000079189, REVEL 0.03, CADD 13.00, Likely benign, not specified; Niemann-Pick disease, type B; Niemann-Pick disease, type A
- V36L (p.Val36Leu), rs141685473, ClinGen CA217298983, ClinVar RCV002591782, ClinVar RCV005744617, REVEL 0.03, CADD 9.98, Uncertain significance, Inborn genetic diseases; Niemann-Pick disease, type A; Niemann-Pick disease, typ
- V36M (p.Val36Met), ESP rs141685473, ExAC rs141685473, TOPMed rs141685473, gnomAD rs141685473, REVEL 0.04, CADD 15.90, Uncertain significance
- p.Val36 Leu45del, gnomAD 11-6390700-CCTGGT, CADD 17.10
- V36W (p.Val36Trp), rs771373973, gnomAD 11-6390702-TGGTGC, CADD 23.50
- V36G (p.Val36Gly), gnomAD 11-6390704-GT-G, CADD 21.80
- p.Val36 Leu37insAlaLeuAlaLeuAlaL, rs775568984, gnomAD 11-6390705-T-TGGC, CADD 11.10
- L37P (p.Leu37Pro), Ensembl rs1847863252, REVEL 0.21, CADD 19.70
- L37G (p.Leu37Gly), gnomAD 11-6390706-GCT-G, CADD 22.30
- L37A (p.Leu37Ala), gnomAD 11-6390706-GCTGGC, CADD 22.10
- L37W (p.Leu37Trp), rs761696094, gnomAD 11-6390706-GC-G, CADD 14.20
- p.Leu37 Ala40delinsPro, rs767338533, gnomAD 11-6390707-CTGGCG, CADD 15.10
- A38E (p.Ala38Glu), rs71467507, ClinGen CA5852492, ClinVar RCV000594768, ClinVar RCV002531016, REVEL 0.08, CADD 0.87, Uncertain significance, not provided; Niemann-Pick disease, type A; Niemann-Pick disease, type B
- A38T (p.Ala38Thr), gnomAD rs1847863697, REVEL 0.01, CADD 6.61
- A38V (p.Ala38Val), rs71467507, ClinGen CA5852493, cosmic curated COSV54966, ClinVar RCV000675386, REVEL 0.01, CADD 0.38, Uncertain significance, Niemann-Pick disease, type B; Niemann-Pick disease, type A; not provided
- A38G (p.Ala38Gly), rs773261292, gnomAD 11-6390708-TGGCGC, CADD 23.20
- A38W (p.Ala38Trp), gnomAD 11-6390709-GGCGC-, CADD 23.30
- A38A (p.Ala38Ala), rs1195507316, gnomAD 11-6390712-G-T, CADD 7.34
- L39P (p.Leu39Pro), NCI-TCGA TCGA novel, TOPMed rs1364641401, gnomAD rs1364641401, REVEL 0.21, CADD 23.80, Variant assessed as somatic; moderate impact.
- L39Q (p.Leu39Gln), TOPMed rs1364641401, gnomAD rs1364641401
- L39V (p.Leu39Val), cosmic curated COSV54966, Ensembl rs1847864154, Likely benign
- L39G (p.Leu39Gly), gnomAD 11-6390709-GGC-G, CADD 17.00
- p.Leu39 Ala40insValLeu, rs1464778478, gnomAD 11-6390711-C-CGCT, CADD 8.55
- L39R (p.Leu39Arg), rs1316694521, gnomAD 11-6390713-CT-C, CADD 23.00
- L39L (p.Leu39Leu), rs1436174840, gnomAD 11-6390715-G-A, CADD 9.43
- A40P (p.Ala40Pro), rs1299899778, ClinGen CA379367284, ClinVar RCV000666400, TOPMed rs1299899778, Uncertain significance, Niemann-Pick disease, type A
- A40T (p.Ala40Thr), TOPMed rs1299899778, gnomAD rs1299899778, Uncertain significance
- A40V (p.Ala40Val), cosmic curated COSV54970, ESP rs377374691, gnomAD rs377374691, REVEL 0.01, CADD 12.00
- A40W (p.Ala40Trp), gnomAD 11-6390714-TGGCG-, CADD 23.70
- A40A (p.Ala40Ala), rs1847864828, gnomAD 11-6390718-G-T, CADD 7.77
- L41P (p.Leu41Pro), rs760549042, ExAC rs760549042, TOPMed rs760549042, gnomAD rs760549042, REVEL 0.24, CADD 22.20, Variant assessed as somatic; moderate impact.
- L41Q (p.Leu41Gln), NCI-TCGA TCGA novel, REVEL 0.23, CADD 23.20, Variant assessed as somatic; moderate impact.
- L41V (p.Leu41Val), Ensembl rs1489451470
- A42E (p.Ala42Glu), Ensembl rs200577287
- A42S (p.Ala42Ser), Ensembl rs1554933846
- A42V (p.Ala42Val), Ensembl rs200577287
- p.Ala42 Leu49del, rs3838786, gnomAD 11-6390705-TGCTGG, CADD 15.50
- p.Ala42 Leu43insProAla, rs1458099873, gnomAD 11-6390720-T-TGGC, CADD 13.60
- A42G (p.Ala42Gly), gnomAD 11-6390720-TGGCGC, CADD 19.80
- A42A (p.Ala42Ala), rs571806745, gnomAD 11-6390724-G-T, CADD 5.24
- L43P (p.Leu43Pro), gnomAD rs1255290838, REVEL 0.10, CADD 22.80
- p.Leu43 Ala44insValLeuAlaLeuAlaL, gnomAD 11-6390711-C-CGCT, CADD 8.07
- L43Q (p.Leu43Gln), gnomAD 11-6390726-T-A, REVEL 0.06, CADD 22.70
- A44E (p.Ala44Glu), ExAC rs776573567, TOPMed rs776573567, gnomAD rs776573567, REVEL 0.01, CADD 14.20
- A44P (p.Ala44Pro), TOPMed rs1201900242, gnomAD rs1201900242, REVEL 0.05, CADD 13.50
- A44V (p.Ala44Val), ExAC rs776573567, TOPMed rs776573567, gnomAD rs776573567, REVEL 0.02, CADD 13.70
- p.Ala44 Leu49del, rs3838786, gnomAD 11-6390705-TGCTGG, CADD 15.70
- A44R (p.Ala44Arg), gnomAD 11-6390726-TG-T, CADD 21.60
- A44A (p.Ala44Ala), rs1554933861, gnomAD 11-6390730-G-T, CADD 6.93
- L45M (p.Leu45Met), ExAC rs761899078
- L45G (p.Leu45Gly), rs1345646067, gnomAD 11-6390727-GGC-G, CADD 21.60
- L45L (p.Leu45Leu), rs150867628, gnomAD 11-6390733-G-T, CADD 5.37
- A46V (p.Ala46Val), Ensembl rs1299705847
- p.Ala46 Leu49del, rs3838786, gnomAD 11-6390705-TGCTGG, CADD 15.00
- A46W (p.Ala46Trp), rs1464153315, gnomAD 11-6390732-TGGCG-, CADD 17.80
- A46G (p.Ala46Gly), gnomAD 11-6390732-TGGCGC, CADD 17.30
- A46A (p.Ala46Ala), rs200763765, gnomAD 11-6390736-G-A, CADD 7.63
- L47Q (p.Leu47Gln), gnomAD rs1249315685, REVEL 0.05, CADD 21.00
- L47V (p.Leu47Val), gnomAD 11-6390734-GCGCTG, CADD 21.40
- A48P (p.Ala48Pro), ExAC rs766902025
- A48S (p.Ala48Ser), ExAC rs766902025
- A48V (p.Ala48Val), cosmic curated COSV54971, TOPMed rs1847867448, REVEL 0.01, CADD 8.21
- p.Ala48 Leu49del, rs3838786, gnomAD 11-6390705-TGCTGG, CADD 11.20
- A48L (p.Ala48Leu), gnomAD 11-6390738-TG-T, CADD 16.70
- A48A (p.Ala48Ala), rs751904073, gnomAD 11-6390742-T-G, CADD 7.83
- p.Leu49 Ser50del, rs1382534368, gnomAD 11-6390740-GCTCTG, CADD 12.60
- p.Leu49 Ser50insAlaLeuGlyLeu, gnomAD 11-6390741-C-CGCT, CADD 8.66
- S50A (p.Ser50Ala), ExAC rs781675416, REVEL 0.01, CADD 1.02, Uncertain significance
- S50P (p.Ser50Pro), rs781675416, ClinGen CA379367531, ClinVar RCV000597540, ExAC rs781675416, REVEL 0.01, CADD 1.04, Uncertain significance, not provided
- S50L (p.Ser50Leu), gnomAD 11-6390745-GT-G, CADD 12.50
- S50G (p.Ser50Gly), gnomAD 11-6390745-GTCTGA, CADD 23.50
- S50W (p.Ser50Trp), gnomAD 11-6390746-T-TGGC, CADD 18.90
- D51G (p.Asp51Gly), ExAC rs748589919, TOPMed rs748589919, gnomAD rs748589919, REVEL 0.05, CADD 17.50, Likely pathogenic, in NPDB
- D51V (p.Asp51Val), rs748589919, ClinGen CA5852508, ClinVar RCV001579137, ClinVar RCV001579138, REVEL 0.16, CADD 23.10, Conflicting interpretations, Niemann-Pick disease, type B; Niemann-Pick disease, type A; not provided
- D51L (p.Asp51Leu), rs1057516949, gnomAD 11-6390746-TCTGA-, CADD 22.80
Public SMPD1 analysis runs
- SMPD1 analysis run — SMPD1 (1,242 variants) — completed 2026-08-19